Chris Freeman - 15 Jun 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Chris Freeman
Issuer symbol
GH
Transactions as of
15 Jun 2024
Net transactions value
-$86,703
Form type
4
Filing time
17 Jun 2024, 18:40:10 UTC
Previous filing
02 Apr 2024
Next filing
02 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +4,879 +29% $0.000000 21,946 15 Jun 2024 Direct
transaction GH Common Stock Options Exercise $0 +5,523 +25% $0.000000 27,469 15 Jun 2024 Direct
transaction GH Common Stock Tax liability $86,703 -2,870 -10% $30.21 24,599 15 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -4,879 -50% $0.000000 4,879 15 Jun 2024 Common Stock 4,879 $0.000000 Direct F2, F3
transaction GH Restricted Stock Units Options Exercise $0 -5,523 -33% $0.000000 11,215 15 Jun 2024 Common Stock 5,523 $0.000000 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit vests as to 25% of the shares subject to such award on June 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of June 15, 2022, during the three-year period thereafter.
F3 Not applicable to Restricted Stock Units
F4 This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F5 Not applicable for Restricted Stock Units.

Remarks:

Table I includes 1,096 shares acquired under Guardant Health's Employee Stock Purchase Plan on 5/14/2024.